Intravenous vs. Intracoronary Use of Abciximab.

Trial Profile

Intravenous vs. Intracoronary Use of Abciximab.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2011

At a glance

  • Drugs Abciximab (Primary) ; Abciximab (Primary)
  • Indications Coronary stent thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2011 Results published in Cardiology.
    • 09 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Nov 2009 Results presented at the 82nd Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top